Torsades de pointes with terfenadine ingestion

Area of Science:

• Cardiology
• Pharmacology
• Clinical Medicine

Background:

• Torsades de pointes (TDP) is a life-threatening ventricular arrhythmia.
• TDP is typically associated with terfenadine in patients with predisposing factors like liver disease, electrolyte imbalances, or drug interactions.
• Risk factors include concomitant use of cytochrome P-450 inhibitors and overdose.

Observation:

• This report details the first documented case of TDP in a healthy patient.
• The patient was administered the recommended therapeutic dosage of terfenadine.
• No other known risk factors for TDP were present in this individual.

Findings:

• Terfenadine, even at recommended doses, can precipitate Torsades de pointes in healthy individuals.
• The absence of typical risk factors suggests a direct proarrhythmic effect of terfenadine.
• This finding challenges the established understanding of terfenadine-induced TDP risk.

Implications:

• Clinicians should be aware of the potential for TDP in healthy patients taking terfenadine.
• This case may necessitate a re-evaluation of terfenadine's safety profile.
• Further research is warranted to elucidate the mechanisms underlying TDP in this context.